iFast Diagnostics
Northampton · Founded 2022
About iFast Diagnostics
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.1M
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: https://ifastdiagnostics.com/
- Phone: +44 (0)7788 595176
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/ifast-diagnostics-57503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.